- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
New Arkansas Governor Plans to Replace Medicaid Expansion After 2016
Newly elected Arkansas Gov Asa Hutchinson said he wants to continue the state's Medicaid expansion compromise through December 31, 2016, but he is keeping his options open for a new plan in the future.
Newly elected Arkansas Gov Asa Hutchinson said he wants to continue the state’s Medicaid expansion compromise through December 31, 2016, but he is keeping his options open for a new plan in the future. The Republican replaced Democrat Mike Beebe.
In a speech at the University of Arkansas Medical School, Mr Hutchinson said he will create a legislative task force to consider better healthcare options for 2017 and beyond.
“It is time to close this chapter and to start a new one,” he said during the speech. “It is a new day for healthcare in Arkansas.”
The Arkansas Medicaid expansion uses federal dollars to help low-income people purchase private health insurance plans and had been rejected 4 previous times by the state’s House of Representatives before narrowly passing.
The funds for the so-called “private option” of Medicaid expansion must be re-authorized each year by a three-fourths majority. The governor is now asking the 100-member House and 35-member Senate to re-authorize the program for one more year.
Former Arkansas Surgeon General Joe Thompson, MD, spoke to AJMCtv about the state’s Medicaid expansion compromise in October, shortly before the mid-term elections. The state was interested in expanding Medicaid because it played into a larger plan for system-wide transformation.
Dr Joe Thompson on the Arkansas “Private Option” Medicaid Expansion.
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
